Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. [electronic resource]
Producer: 20051018Description: 1213-5 p. digitalISSN:- 0145-2126
- Adult
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- therapeutic use
- Antilymphocyte Serum -- administration & dosage
- Antineoplastic Agents -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Cyclosporine -- administration & dosage
- Dexamethasone -- administration & dosage
- Drug Resistance, Neoplasm
- Humans
- Leukemia, T-Cell -- complications
- Male
- Mitoxantrone -- administration & dosage
- Prednisolone -- administration & dosage
- Red-Cell Aplasia, Pure -- complications
- Remission Induction
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.